Literature DB >> 26921343

TGFβ Signaling Intersects with CD103 Integrin Signaling to Promote T-Lymphocyte Accumulation and Antitumor Activity in the Lung Tumor Microenvironment.

Marie Boutet1, Ludiane Gauthier1, Marine Leclerc1, Gwendoline Gros1, Vincent de Montpreville2, Nathalie Théret3, Emmanuel Donnadieu4, Fathia Mami-Chouaib5.   

Abstract

Homing of CD8(+) T lymphocytes to the tumor microenvironment is an important step for mounting a robust antitumor immune response. TGFβ is responsible for CD103 (αEβ7) integrin induction in activated intraepithelial CD8(+) T lymphocytes. However, the interplay between TGFβ and CD103 and their contribution to T-cell infiltration and antitumor activity remain unknown. Here, we used viable human lung tumor slices and autologous tumor antigen-specific T-lymphocyte clones to provide evidence that CD103 is directly involved in T-lymphocyte recruitment within epithelial tumor islets and intratumoral early T-cell signaling. Moreover, TGFβ enhanced CD103-dependent T-cell adhesion and signaling, whereas it inhibited leukocyte function-associated antigen (LFA)-1 (αLβ2) integrin expression and LFA-1-mediated T-lymphocyte functions. Mechanistic investigations revealed that TGFβ bound to its receptors (TGFBR), which promoted the recruitment and phosphorylation of integrin-linked kinase (ILK) by TGFBR1. We further show that ILK interacted with the CD103 intracellular domain, resulting in protein kinase B (PKB)/AKT activation, thereby initiating integrin inside-out signaling. Collectively, our findings suggest that the abundance of TGFβ in the tumor microenvironment may in fact engage with integrin signaling pathways to promote T-lymphocyte antitumor functions, with potential implications for T-cell-based immunotherapies for cancer. Cancer Res; 76(7); 1757-69. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26921343     DOI: 10.1158/0008-5472.CAN-15-1545

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  34 in total

1.  Differential regulation of CD103 (αE integrin) expression in human dendritic cells by retinoic acid and Toll-like receptor ligands.

Authors:  Mandi M Roe; Steve Swain; T Andrew Sebrell; Marisa A Sewell; Madison M Collins; Brian A Perrino; Phillip D Smith; Lesley E Smythies; Diane Bimczok
Journal:  J Leukoc Biol       Date:  2017-01-13       Impact factor: 4.962

2.  Up-regulation of LFA-1 allows liver-resident memory T cells to patrol and remain in the hepatic sinusoids.

Authors:  H A McNamara; Y Cai; M V Wagle; Y Sontani; C M Roots; L A Miosge; J H O'Connor; H J Sutton; V V Ganusov; W R Heath; P Bertolino; C G Goodnow; I A Parish; A Enders; I A Cockburn
Journal:  Sci Immunol       Date:  2017-03-17

Review 3.  Environmental cues orchestrate regional immune surveillance and protection by pulmonary CTLs.

Authors:  Linda S Cauley
Journal:  J Leukoc Biol       Date:  2016-06-17       Impact factor: 4.962

4.  TGF-β enhances the cytotoxic activity of Vδ2 T cells.

Authors:  Christian Peters; Annika Meyer; Léonce Kouakanou; Julia Feder; Tim Schricker; Marcus Lettau; Ottmar Janssen; Daniela Wesch; Dieter Kabelitz
Journal:  Oncoimmunology       Date:  2018-09-26       Impact factor: 8.110

5.  The tissue-resident marker CD103 on peripheral blood T cells predicts responses to anti-PD-1 therapy in gastric cancer.

Authors:  Yohei Nose; Takuro Saito; Kei Yamamoto; Kotaro Yamashita; Koji Tanaka; Kazuyoshi Yamamoto; Tomoki Makino; Tsuyoshi Takahashi; Atsunari Kawashima; Miya Haruna; Michinari Hirata; Azumi Ueyama; Kota Iwahori; Taroh Satoh; Yukinori Kurokawa; Hidetoshi Eguchi; Yuichiro Doki; Hisashi Wada
Journal:  Cancer Immunol Immunother       Date:  2022-07-01       Impact factor: 6.968

Review 6.  Overcoming TGFβ-mediated immune evasion in cancer.

Authors:  Daniele V F Tauriello; Elena Sancho; Eduard Batlle
Journal:  Nat Rev Cancer       Date:  2021-10-20       Impact factor: 60.716

Review 7.  Tissue-resident memory T cells in breast cancer control and immunotherapy responses.

Authors:  Ann Byrne; Peter Savas; Sneha Sant; Ran Li; Balaji Virassamy; Stephen J Luen; Paul A Beavis; Laura K Mackay; Paul J Neeson; Sherene Loi
Journal:  Nat Rev Clin Oncol       Date:  2020-02-28       Impact factor: 66.675

8.  Self-Maintaining CD103+ Cancer-Specific T Cells Are Highly Energetic with Rapid Cytotoxic and Effector Responses.

Authors:  Yanchun Peng; Tao Dong; Megat Abd Hamid; Huw Colin-York; Nasullah Khalid-Alham; Molly Browne; Lucia Cerundolo; Ji-Li Chen; Xuan Yao; Samara Rosendo-Machado; Craig Waugh; David Maldonado-Perez; Emma Bowes; Clare Verrill; Vincenzo Cerundolo; Christopher P Conlon; Marco Fritzsche
Journal:  Cancer Immunol Res       Date:  2019-11-26       Impact factor: 11.151

9.  The SKI proto-oncogene restrains the resident CD103+CD8+ T cell response in viral clearance.

Authors:  Bing Wu; Ge Zhang; Zengli Guo; Gang Wang; Xiaojiang Xu; Jian-Liang Li; Jason K Whitmire; Junnian Zheng; Yisong Y Wan
Journal:  Cell Mol Immunol       Date:  2020-07-01       Impact factor: 22.096

10.  CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer.

Authors:  Fenne L Komdeur; Thalina M Prins; Stephanie van de Wall; Annechien Plat; G Bea A Wisman; Harry Hollema; Toos Daemen; David N Church; Marco de Bruyn; Hans W Nijman
Journal:  Oncoimmunology       Date:  2017-07-24       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.